Thursday, August 15, 2019 9:54:23 AM
now say.Phase III SOLID TUMORS IS OKI.FDA aproval the drug for this tipe of tumors.
PBYI go to 100 dolars next week
We had 1.5Millions shares bought with JP MORGAN
YOU CAN SEE IT................LETS GO TRADERS.
nEXT MONTH I WRITE!!!
Recent PBYI News
- Puma Biotechnology Reports First Quarter Financial Results • Business Wire • 05/02/2024 08:05:00 PM
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results • Business Wire • 04/18/2024 08:15:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/03/2024 09:30:00 PM
- Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer • Business Wire • 03/20/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:16:09 PM
- Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/29/2024 09:05:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/27/2024 11:30:00 PM
- Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference • Business Wire • 02/22/2024 09:10:00 PM
- Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/15/2024 09:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:03:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:01:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:54:09 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:19:11 PM
- Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer • Business Wire • 02/13/2024 01:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 08:54:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 02:00:45 PM
- Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference • Business Wire • 01/11/2024 09:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:41:48 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 01/10/2024 09:38:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 12:03:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 12:00:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 11:49:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 11:42:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/04/2024 02:40:50 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM